Did Neuralink make the wrong bet?
Neuralink is pivoting from motor-control brain-computer interfaces (BCIs) to speech restoration—a strategic shift that reflects the field moving faster than the company's original vision of human-AI enhancement. Competitors have demonstrated superior clinical outcomes with speech BCIs (97% accuracy in natural speech), forcing Neuralink to course-correct despite years of investment in cursor-control technology and significant public overpromising by leadership. This pivot represents a critical lesson for technology leaders: ambitious visions must align with scientific reality, and organizations must be willing to shift strategies when market fundamentals and clinical evidence contradict initial assumptions.
The Verge2 min read
Elon Musk promised Neuralink would bring superhuman abilities and minds merged with AI. Then he fueled a runaway hype train for his brain implant technology, which ended up with a grisly record for implants in monkeys and some success with human subjects. But for all of the hype, he's still further away than Mars from his goal. And that's because his relentless ambition is once again hitting the wall of scientific reality. The heart of the issue is how brain-computer interfaces (BCIs) translate thought into results. Neuralink's products have all been brain-to-cursor interfaces, which allow patients to control a mouse with their minds. But N … Read the full story at The Verge.